IBDEI17A ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20410,2)
 ;;=^5009621
 ;;^UTILITY(U,$J,358.3,20411,0)
 ;;=M86.20^^84^931^62
 ;;^UTILITY(U,$J,358.3,20411,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20411,1,3,0)
 ;;=3^Osteomyelitis,Subacute,Unspec Site
 ;;^UTILITY(U,$J,358.3,20411,1,4,0)
 ;;=4^M86.20
 ;;^UTILITY(U,$J,358.3,20411,2)
 ;;=^5014535
 ;;^UTILITY(U,$J,358.3,20412,0)
 ;;=M86.10^^84^931^58
 ;;^UTILITY(U,$J,358.3,20412,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20412,1,3,0)
 ;;=3^Osteomyelitis,Acute,Unspec Site
 ;;^UTILITY(U,$J,358.3,20412,1,4,0)
 ;;=4^M86.10
 ;;^UTILITY(U,$J,358.3,20412,2)
 ;;=^5014521
 ;;^UTILITY(U,$J,358.3,20413,0)
 ;;=M86.00^^84^931^57
 ;;^UTILITY(U,$J,358.3,20413,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20413,1,3,0)
 ;;=3^Osteomyelitis,Acute Hematogenous,Unspec Site
 ;;^UTILITY(U,$J,358.3,20413,1,4,0)
 ;;=4^M86.00
 ;;^UTILITY(U,$J,358.3,20413,2)
 ;;=^5014497
 ;;^UTILITY(U,$J,358.3,20414,0)
 ;;=M86.50^^84^931^59
 ;;^UTILITY(U,$J,358.3,20414,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20414,1,3,0)
 ;;=3^Osteomyelitis,Chronic Hematogenous,Unspec Site
 ;;^UTILITY(U,$J,358.3,20414,1,4,0)
 ;;=4^M86.50
 ;;^UTILITY(U,$J,358.3,20414,2)
 ;;=^5014607
 ;;^UTILITY(U,$J,358.3,20415,0)
 ;;=M86.30^^84^931^60
 ;;^UTILITY(U,$J,358.3,20415,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20415,1,3,0)
 ;;=3^Osteomyelitis,Chronic Multifocal,Unspec Site
 ;;^UTILITY(U,$J,358.3,20415,1,4,0)
 ;;=4^M86.30
 ;;^UTILITY(U,$J,358.3,20415,2)
 ;;=^5014559
 ;;^UTILITY(U,$J,358.3,20416,0)
 ;;=M86.8X9^^84^931^63
 ;;^UTILITY(U,$J,358.3,20416,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20416,1,3,0)
 ;;=3^Osteomyelitis,Unspec Sites
 ;;^UTILITY(U,$J,358.3,20416,1,4,0)
 ;;=4^M86.8X9
 ;;^UTILITY(U,$J,358.3,20416,2)
 ;;=^5014655
 ;;^UTILITY(U,$J,358.3,20417,0)
 ;;=M86.60^^84^931^61
 ;;^UTILITY(U,$J,358.3,20417,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20417,1,3,0)
 ;;=3^Osteomyelitis,Chronic,Unspec Site
 ;;^UTILITY(U,$J,358.3,20417,1,4,0)
 ;;=4^M86.60
 ;;^UTILITY(U,$J,358.3,20417,2)
 ;;=^5014630
 ;;^UTILITY(U,$J,358.3,20418,0)
 ;;=M86.40^^84^931^56
 ;;^UTILITY(U,$J,358.3,20418,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20418,1,3,0)
 ;;=3^Osteomyelitis w/ Draining Sinus,Chronic,Unspec Site
 ;;^UTILITY(U,$J,358.3,20418,1,4,0)
 ;;=4^M86.40
 ;;^UTILITY(U,$J,358.3,20418,2)
 ;;=^5014583
 ;;^UTILITY(U,$J,358.3,20419,0)
 ;;=R50.2^^84^931^23
 ;;^UTILITY(U,$J,358.3,20419,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20419,1,3,0)
 ;;=3^Fever,Drug-Induced
 ;;^UTILITY(U,$J,358.3,20419,1,4,0)
 ;;=4^R50.2
 ;;^UTILITY(U,$J,358.3,20419,2)
 ;;=^5019507
 ;;^UTILITY(U,$J,358.3,20420,0)
 ;;=R50.9^^84^931^27
 ;;^UTILITY(U,$J,358.3,20420,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20420,1,3,0)
 ;;=3^Fever,Unspec
 ;;^UTILITY(U,$J,358.3,20420,1,4,0)
 ;;=4^R50.9
 ;;^UTILITY(U,$J,358.3,20420,2)
 ;;=^5019512
 ;;^UTILITY(U,$J,358.3,20421,0)
 ;;=R76.11^^84^931^1
 ;;^UTILITY(U,$J,358.3,20421,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20421,1,3,0)
 ;;=3^Abnormal Reaction to TB Test w/o Active TB
 ;;^UTILITY(U,$J,358.3,20421,1,4,0)
 ;;=4^R76.11
 ;;^UTILITY(U,$J,358.3,20421,2)
 ;;=^5019570
 ;;^UTILITY(U,$J,358.3,20422,0)
 ;;=Z21.^^84^931^30
 ;;^UTILITY(U,$J,358.3,20422,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20422,1,3,0)
 ;;=3^HIV Asymptomatic,Infection Status
 ;;^UTILITY(U,$J,358.3,20422,1,4,0)
 ;;=4^Z21.
 ;;^UTILITY(U,$J,358.3,20422,2)
 ;;=^5062777
 ;;^UTILITY(U,$J,358.3,20423,0)
 ;;=B37.0^^84^931^16
 ;;^UTILITY(U,$J,358.3,20423,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20423,1,3,0)
 ;;=3^Candidal Stomatitis (Oral Thrush)
 ;;^UTILITY(U,$J,358.3,20423,1,4,0)
 ;;=4^B37.0
